{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:26Z","timestamp":1762868126962,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jdcr.2020.04.016","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T02:44:45Z","timestamp":1587696285000},"page":"567-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum"],"prefix":"10.1016","volume":"6","author":[{"given":"Erisa","family":"Alia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakaash","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Brody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Keyzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jdcr.2020.04.016_bib1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/cup.12326","article-title":"Ponatinib-induced neutrophilic panniculitis","volume":"41","author":"Zhang","year":"2014","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jdcr.2020.04.016_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2147\/OTT.S189391","article-title":"Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies","volume":"12","author":"Tan","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jdcr.2020.04.016_bib3","first-page":"50","article-title":"Vasculitis, neutrophilic dermatoses and related disorders","volume":"3","author":"Cox","year":"2010"},{"key":"10.1016\/j.jdcr.2020.04.016_bib4","series-title":"Dermatology","first-page":"1641","article-title":"Panniculitis","author":"Patterson","year":"2012"},{"issue":"5","key":"10.1016\/j.jdcr.2020.04.016_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2230.1999.00511.x","article-title":"Leucocyte activation in erythema nodosum","volume":"24","author":"Kunz","year":"1999","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2020.04.016_bib6","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1111\/ijd.13212","article-title":"Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum","volume":"55","author":"De Simone","year":"2016","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2020.04.016_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/000155501750208128","article-title":"Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum","volume":"81","author":"Labunski","year":"2001","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jdcr.2020.04.016_bib8","first-page":"50","article-title":"Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions","volume":"58","author":"Chodorowska","year":"2003","journal-title":"Ann Univ Mariae Curie Sklodowska Med"},{"issue":"3","key":"10.1016\/j.jdcr.2020.04.016_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ecco-jcc\/jjx158","article-title":"Expression patterns of TNF\u03b1, MAdCAM1, and STAT3 in intestinal and skin manifestations of inflammatory bowel disease","volume":"12","author":"Vavricka","year":"2018","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.jdcr.2020.04.016_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1540-9740.2007.05882.x","article-title":"Etanercept treatment of erythema nodosum","volume":"6","author":"Boyd","year":"2007","journal-title":"Skin Med"},{"issue":"11","key":"10.1016\/j.jdcr.2020.04.016_bib11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ajh.20926","article-title":"TNF-\u03b1 inhibitor etanercept and hematologic malignancies: report of a case and review of the literature","volume":"82","author":"Nair","year":"2007","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.jdcr.2020.04.016_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/ard.2004.021378","article-title":"Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab","volume":"64","author":"Broussais","year":"2005","journal-title":"Ann Rheum Dis"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620302903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620302903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:21:11Z","timestamp":1762474871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512620302903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2352512620302903"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.04.016","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}